ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+7.15%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$4.06B
AUM Growth
+$411M
(+11%)
Cap. Flow
+$232M
Cap. Flow
% of AUM
5.72%
Top 10 Holdings %
Top 10 Hldgs %
21.64%
Holding
1,420
New
288
Increased
397
Reduced
560
Closed
115
Top Buys
| 1 |
Vanguard Long-Term Bond ETF
BLV
|
+$158M |
| 2 |
iShares Core US REIT ETF
USRT
|
+$141M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$138M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$101M |
| 5 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$69.2M |
Top Sells
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$731M |
| 2 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$487M |
| 3 |
NVIDIA
NVDA
|
+$38.6M |
| 4 |
Verizon
VZ
|
+$19.7M |
| 5 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$18.9M |
Sector Composition
| 1 | Technology | 20.92% |
| 2 | Energy | 10.24% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 5.82% |
| 5 | Consumer Discretionary | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Bank of America
BAC
$376B
| $162K | ﹤0.01% |
5,656
+392
| +7% | +$11.2K |
|
827
WEX
WEX
$6.04B
| $162K | ﹤0.01% |
+890
| New | +$162K |
|
|
AMAM
828
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $162K | ﹤0.01% |
+9,830
| New | +$162K |
|
|
MCHB
829
Mechanics Bancorp Class A Common Stock
MCHB
$3.07B
| $160K | ﹤0.01% |
27,052
| – | – |
|
830
Zentalis Pharmaceuticals
ZNTL
$113M
| $159K | ﹤0.01% |
+5,654
| New | +$159K |
|
831
Allegion
ALLE
$15.2B
| $159K | ﹤0.01% |
1,325
-235
| -15% | -$28.2K |
|
832
Cable One
CABO
$1B
| $156K | ﹤0.01% |
237
+3
| +1% | +$1.97K |
|
|
BPMC
833
DELISTED
Blueprint Medicines
BPMC
| $154K | ﹤0.01% |
+2,438
| New | +$154K |
|
834
PagSeguro Digital
PAGS
$2.77B
| $153K | ﹤0.01% |
16,198
+1,251
| +8% | +$11.8K |
|
835
Arrow Electronics
ARW
$6.66B
| $152K | ﹤0.01% |
1,064
-57
| -5% | -$8.16K |
|
836
Acrivon Therapeutics
ACRV
$48.8M
| $152K | ﹤0.01% |
+11,709
| New | +$152K |
|
837
Erie Indemnity
ERIE
$17.7B
| $152K | ﹤0.01% |
+722
| New | +$152K |
|
838
Relay Therapeutics
RLAY
$710M
| $152K | ﹤0.01% |
+12,067
| New | +$152K |
|
839
Tyra Biosciences
TYRA
$665M
| $151K | ﹤0.01% |
+8,867
| New | +$151K |
|
840
Syndax Pharmaceuticals
SNDX
$1.41B
| $151K | ﹤0.01% |
7,213
+6,355
| +741% | +$133K |
|
841
Immuneering
IMRX
$341M
| $151K | ﹤0.01% |
+14,884
| New | +$151K |
|
842
C.H. Robinson
CHRW
$15.5B
| $150K | ﹤0.01% |
1,595
-344
| -18% | -$32.5K |
|
|
IMGN
843
DELISTED
Immunogen Inc
IMGN
| $150K | ﹤0.01% |
+7,945
| New | +$150K |
|
844
Revolution Medicines
RVMD
$8.64B
| $149K | ﹤0.01% |
+5,557
| New | +$149K |
|
845
Immunocore
IMCR
$1.84B
| $148K | ﹤0.01% |
+2,476
| New | +$148K |
|
846
Dolby
DLB
$6.91B
| $148K | ﹤0.01% |
1,773
+490
| +38% | +$41K |
|
847
Allison Transmission
ALSN
$7.57B
| $148K | ﹤0.01% |
+2,622
| New | +$148K |
|
848
Genelux
GNLX
$138M
| $145K | ﹤0.01% |
+4,442
| New | +$145K |
|
|
MOR
849
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $144K | ﹤0.01% |
+19,287
| New | +$144K |
|
850
Monte Rosa Therapeutics
GLUE
$302M
| $144K | ﹤0.01% |
+20,996
| New | +$144K |
|